4//SEC Filing
Laxai Pharma Ltd 4
Accession 0001209191-11-015681
CIK 0000835688operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:34 PM ET
Size
13.0 KB
Accession
0001209191-11-015681
Insider Transaction Report
Form 4
Laxai Pharma LtdLAXAF
TOLEDANO UDI
10% OwnerOther
Transactions
- Other
Ordinary Shares
2011-02-18+16,800,000→ 16,800,000 total(indirect: By LLC)
UTA Capital LLC
10% Owner
Transactions
- Other
Ordinary Shares
2011-02-18+16,800,000→ 16,800,000 total(indirect: By LLC)
ALLEGHANY CAPITAL Corp
10% Owner
Transactions
- Other
Ordinary Shares
2011-02-18+16,800,000→ 16,800,000 total(indirect: By LLC)
ALLEGHANY CORP /DE
10% Owner
Transactions
- Other
Ordinary Shares
2011-02-18+16,800,000→ 16,800,000 total(indirect: By LLC)
YZT Management LLC
10% OwnerOther
Transactions
- Other
Ordinary Shares
2011-02-18+16,800,000→ 16,800,000 total(indirect: By LLC)
Footnotes (2)
- [F1]UTA Capital LLC (i) was issued 4,800,000 ordinary shares upon conversion of $240,000 principal amount of indebtedness due from the issuer (ii) was the transferee of an additional 12,000,000 ordinary shares, in each case under a restructuring agreement dated February 18, 2011 (the "Term Sheet"). UTA Capital LLC has no funding obligations in connection with the Term Sheet and the transactions contemplated therein.
- [F2]This Form 4 is being jointly filed by (i) UTA Capital LLC; (ii) the members or beneficial owners of membership interests in UTA Capital LLC, which include (a) YZT Management LLC, a New Jersey limited liability company and the managing member of UTA Capital LLC, and (b) Alleghany Capital Corporation, a Delaware corporation and a member of UTA Capital LLC; (iii) Alleghany Corporation, a publicly-traded Delaware corporation of which Alleghany Capital Corporation is a wholly-owned subsidiary; and (iv) Udi Toledano, the managing member of YZT Management LLC. The reporting persons disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Laxai Pharma Ltd
CIK 0000835688
Entity typeoperating
IncorporatedIsrael
Related Parties
1- filerCIK 0000835688
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:34 PM ET
- Size
- 13.0 KB